- Telehealth Visits
- Insurance plan information
Maria Luisa Gorno-Tempini, MD
Neurology • Memory and Cognitive Disorders Neurology- Telehealth Visits
- Insurance plan information
Maria Luisa Gorno-Tempini, MD
Neurology • Memory and Cognitive Disorders Neurology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Maria Luisa Gorno-Tempini is a neurologist at the UCSF Memory and Aging Center. Her goal in patient care is to use state-of the-art cognitive and imaging techniques to diagnose and treat neurological disorders. She places a particular emphasis on managing dementia and neurodegenerative disorders.
Gorno-Tempini's main research interest is progressive aphasia, impaired ability to speak or understand language.
Gorno-Tempini completed her medical degree and specialty training in neurology in Italy, with a focus on behavioral neurology. She worked for three years in the Functional Imaging Laboratory at University College London, where she also earned a doctorate in imaging neuroscience.
Education & training
Fellowship
- Behavioral Neurology, University College London
Residency
- Clinical Neurology, University of Modena and Reggio Emilia
Degree
- MD, Universita Degli Studi de Brescia
My expertise
My research
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.